Clinical effectiveness, safety and immunogenicity of anti-TNF therapy in Crohn's disease: 12-month data from the PANTS study

被引:0
|
作者
Kennedy, N. A. [1 ]
Heap, G. [1 ,2 ]
Hamilton, B. [1 ]
Walker, G. J. [1 ]
Bewshea, C. [1 ]
Bouri, S. [3 ]
Goodhand, J. [1 ]
Ahmad, T. [1 ]
机构
[1] Univ Exeter, IBD Pharmacogenet, Exeter, Devon, England
[2] Abbvie, Chicago, IL USA
[3] St Marks Hosp, IBD Unit, London, England
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OP031
引用
收藏
页码:S21 / S22
页数:2
相关论文
共 50 条
  • [21] Comparative Effectiveness and Safety of Anti-TNF Agents for Crohn's Disease in Biologic-Naive Patients
    Singh, Siddharth
    Sangaralingham, Lindsey R.
    Heien, Herbert
    Anderson, Stephanie S.
    Shah, Nilay
    Loftus, Edward V.
    GASTROENTEROLOGY, 2015, 148 (04) : S175 - S175
  • [22] Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn's disease
    Aterido, Adria
    Palau, Nuria
    Domenech, Eugeni
    Nos Mateu, Pilar
    Gutierrez, Ana
    Gomollon, Fernando
    Mendoza, Juan L.
    Garcia-Planella, Esther
    Barreiro-de Acosta, Manuel
    Munoz, Fernando
    Vera, Maribel
    Saro, Cristina
    Esteve, Maria
    Andreu, Montserrat
    Chaparro, Maria
    Panes, Julian
    Garcia-Sanchez, Valle
    Lopez-Lasanta, Maria
    Pluma, Andrea
    Codo, Laia
    Garcia-Montero, Andres
    Manye, Josep
    Gisbert, Javier P.
    Marsal, Sara
    Julia, Antonio
    PHARMACOGENOMICS JOURNAL, 2019, 19 (06): : 547 - 555
  • [23] Anti-TNF Alpha Therapy and Orofacial Crohn's Disease in Pediatrics
    Chapuy, Laurence
    Deslandres, Colette
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S71 - S71
  • [24] Anti-TNF induction and maintenance therapy for refractory Crohn's disease
    Hartnell, F. L.
    Radford-Smith, G.
    Jones, L.
    Sewell, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 62 - 62
  • [25] Impact analysis of expanding anti-TNF therapy for Crohn's disease
    Honeycutt, Amanda
    Breck, Andrew
    Bass, Sarah
    Esposito, Dominick
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 11 (02) : 79 - 88
  • [26] SEVERE CARDIOMYOPATHY SECONDARY TO ANTI-TNF THERAPY FOR CROHN'S DISEASE
    Rezik, Mohamed
    Mattina, Deirdre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1042 - 1042
  • [27] Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s disease
    Adrià Aterido
    Núria Palau
    Eugeni Domènech
    Pilar Nos Mateu
    Ana Gutiérrez
    Fernando Gomollón
    Juan L. Mendoza
    Esther Garcia-Planella
    Manuel Barreiro-de Acosta
    Fernando Muñoz
    Maribel Vera
    Cristina Saro
    Maria Esteve
    Montserrat Andreu
    María Chaparro
    Julián Panés
    Valle García-Sánchez
    María López-Lasanta
    Andrea Pluma
    Laia Codó
    Andrés García-Montero
    Josep Manyé
    Javier P. Gisbert
    Sara Marsal
    Antonio Julià
    The Pharmacogenomics Journal, 2019, 19 : 547 - 555
  • [28] Atypical mycobacteria: showerheads, anti-TNF therapy and Crohn's disease
    Desai, Alka A.
    Marks, Daniel J. B.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 695 - 699
  • [29] Anti-TNF Treatment in Crohn's Disease: Toward Tailored Therapy?
    D'Haens, Geert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05): : 1140 - 1141
  • [30] Practical Application of Anti-TNF Therapy for Luminal Crohn's Disease
    Kamm, Michael A.
    Ng, Siew C.
    De Cruz, Peter
    Allen, Patrick
    Hanauer, Stephen B.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (11) : 2366 - 2391